tiprankstipranks
Trending News
More News >
Aardvark Therapeutics, Inc. (AARD)
NASDAQ:AARD
US Market

Aardvark Therapeutics, Inc. (AARD) Income Statement

Compare
108 Followers

Aardvark Therapeutics, Inc. Income Statement

Last quarter (Q3 2025), Aardvark Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Aardvark Therapeutics, Inc.'s net income was $-16.32M. See Aardvark Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 22.79M$ 7.42M$ 11.36M
Depreciation and Amortization
$ 16.00K$ 0.00$ 110.00K
EBITDA
$ -22.65M$ -6.65M$ -9.76M
Operating Income
$ -22.79M$ -7.42M$ -11.36M
Other Income/Expenses
$ 2.20M$ 207.00K$ -2.20M
Pretax Income
$ -20.59M$ -7.21M$ -13.56M
Net Income
$ -20.59M$ -7.21M$ -13.56M
Per Share Metrics
Basic EPS
$ -1.59$ -0.56$ -1.39
Diluted EPS
$ -1.59$ -0.56$ -1.39
Weighted Average Shares Outstanding
12.91M 12.91M 9.73M
Weighted Average Shares Outstanding (Diluted)
12.91M 12.91M 9.73M
Currency in USD

Aardvark Therapeutics, Inc. Earnings and Revenue History